VADA PARKE-GASKIN: Open Payments
NPI 1669906079 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 17 payments from 7 companies in 2025. Trend: 2023 $547 · 2024 $60 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $164 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Alkermes, Inc. | 2 | $38 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, UZEDY, LYBALVI, INGREZZA, COBENFY, REXULTI, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
